Eishin Morita Selected Research

Eishin Morita Research Topics

Disease

23	Exercise-Induced Allergies 04/2021 - 03/2004
21	Hypersensitivity (Allergy) 04/2021 - 03/2004
13	Atopic Dermatitis (Atopic Eczema) 11/2021 - 05/2004
9	Wheat Hypersensitivity (Wheat Allergy) 04/2021 - 06/2009
6	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2020 - 10/2005
6	Urticaria (Hives) 02/2013 - 08/2004
5	Inflammation (Inflammations) 01/2021 - 03/2008
5	Anaphylaxis (Anaphylactic Shock) 12/2019 - 03/2004
4	Dermatitis 11/2021 - 08/2005
4	Bullous Pemphigoid (Pemphigoid) 01/2019 - 11/2015
4	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2017 - 07/2012
3	Pruritus (Itching) 09/2021 - 03/2006
3	Food Hypersensitivity (Food Allergy) 04/2021 - 09/2005
3	Erythema 10/2020 - 08/2004
3	Skin Diseases (Skin Disease) 05/2020 - 03/2006
3	Eosinophilia 03/2019 - 03/2015
3	Exanthema (Rash) 03/2019 - 01/2017
3	Drug-Related Side Effects and Adverse Reactions 03/2015 - 07/2012
2	Fever (Fevers) 01/2021 - 03/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020 - 02/2009
2	Drug Hypersensitivity Syndrome 03/2019 - 03/2015
2	Blister (Bulla) 01/2019 - 08/2005
2	Erythema Multiforme 01/2018 - 01/2017
2	Drug Eruptions (Drug Eruption) 01/2018 - 01/2017
2	Pemphigus (Pemphigus Vulgaris) 07/2017 - 01/2016
2	Extramammary Paget Disease (Paget Disease, Extramammary) 04/2015 - 02/2009
2	Melanoma (Melanoma, Malignant) 04/2015 - 12/2014
1	Chronic Urticaria 01/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 04/2021
1	Cough 01/2021
1	Diarrhea 01/2021
1	Hereditary Angioedemas 01/2021
1	Angioedema 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Nasopharyngitis 01/2021
1	Ichthyosis (Xeroderma) 10/2020
1	Fibrosis (Cirrhosis) 05/2020
1	Lymphedema (Milroy Disease) 05/2020
1	Atrophy 05/2020
1	Ulcerative Colitis 04/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Hyperbilirubinemia 01/2020

Drug/Important Bio-Agent (IBA)

26	Immunoglobulin E (IgE)IBA 01/2022 - 03/2004
18	GliadinIBA 04/2021 - 03/2004
18	AllergensIBA 04/2021 - 03/2004
16	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2004
11	AntibodiesIBA 01/2022 - 10/2011
7	Pharmaceutical PreparationsIBA 09/2021 - 07/2012
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2013 - 03/2007
6	Soaps (Soap)IBA 11/2019 - 07/2011
5	EpitopesIBA 07/2019 - 03/2004
5	Immunoglobulin G (IgG)IBA 07/2019 - 11/2015
4	AutoantibodiesIBA 01/2022 - 01/2016
4	Glutens (Glutelin)IBA 12/2019 - 12/2005
4	Chemokine CCL17IBA 01/2018 - 05/2004
4	gluteninIBA 12/2013 - 12/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 10/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	AntigensIBA 07/2017 - 06/2009
3	Carbamazepine (Tegretol)FDA LinkGeneric 04/2014 - 07/2012
2	Amino Acids FDA Link 11/2021 - 10/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 12/2011
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2013
2	Therapeutic UsesIBA 01/2021 - 05/2020
2	Thymic Stromal LymphopoietinIBA 10/2020 - 09/2020
2	CytokinesIBA 05/2020 - 05/2004
2	Immunoglobulin A (IgA)IBA 04/2020 - 08/2004
2	Chromogranin AIBA 05/2018 - 08/2017
2	DesmogleinsIBA 07/2017 - 01/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2014 - 09/2012
2	HLA-A31 antigenIBA 04/2014 - 07/2012
2	Misoprostol (Cytotec)FDA LinkGeneric 02/2011 - 10/2009
2	wheat omega-5 gliadinIBA 08/2007 - 09/2005
1	IgE Receptors (Fc epsilon RI)IBA 01/2022
1	Filaggrin ProteinsIBA 11/2021
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 09/2021
1	Histamine Antagonists (Antihistamines)IBA 09/2021
1	beta-GlucosidaseIBA 04/2021
1	Plasma KallikreinIBA 01/2021
1	berotralstatIBA 01/2021
1	P-2 (P 2)IBA 01/2021
1	Petrolatum (Vaseline)FDA Link 10/2020
1	Interleukin-33IBA 09/2020
1	dupilumabIBA 09/2020
1	PeriostinIBA 09/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2020
1	Interleukin-13IBA 09/2020
1	Interleukin-22 (IL-22)IBA 09/2020
1	CC ChemokinesIBA 09/2020
1	LigandsIBA 09/2020
1	AdipokinesIBA 05/2020
1	Uncoupling Protein 1IBA 05/2020
1	Keratins (Keratin)IBA 05/2020
1	Messenger RNA (mRNA)IBA 05/2020
1	Omalizumab (Xolair)FDA Link 04/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2005
2	Drug Therapy (Chemotherapy) 04/2015 - 04/2011
1	Transplantation 05/2020